Molecular factors of 5-fluorouracil metabolism in colorectal cancer: Analysis of primary tumor and lymph node metastasis

International Journal of Oncology

Volumn 28, Issue 2, 2006, Pages 527-533

  Vallbohmer D ^a,b   Kuramochi, H ^a   Shimizu, D ^a   Danenberg, K D ^c   Lindebjerg, J ^d   Nielsen, J N ^c   Jakobsen, A ^c   Danenberg, Peter V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Response Genetics Inc   (United States)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

5 fluorouracil; Metastatic colorectal cancer; Molecular determinants

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; MESSENGER RNA; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

AGED; ARTICLE; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; DIHYDROURACIL DEHYDROGENASE (NADP); FEMALE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; RNA, MESSENGER; THYMIDINE PHOSPHORYLASE; THYMIDYLATE SYNTHASE;

EID: 33750702299     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.28.2.527     Document Type: Article

References (27)

1. Grem JL: Intratumoral molecular or genetic markers as predictors of clinical outcome with chemotherapy in colorectal cancer. Semin Oncol 32: 120-127, 2005.
2. Leichman CG, Lenz HJ, Leichman L, Danenberg K, Baranda J, Groshen S, Boswell W, Metzger R, Tan M and Danenberg PV: Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. J Clin Oncol 15: 3223-3229, 1997.
3. Metzger R, Danenberg K, Leichman CG, Salonga D, Schwartz EL, Wadler S, Lenz HJ, Groshen S, Leichman L and Danenberg PV: High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with non-response to 5-fluorouracil. Clin Cancer Res 4: 2371-2376, 1998.
4. Salonga D, Danenberg KD, Johnson M, Metzger R, Groshen S, Tsao-Wei DD, Lenz HJ, Leichman CG, Leichman L, Diasio RB and Danenberg PV: Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase and thymidine phosphorylase. Clin Cancer Res 6: 1322-1327, 2000.
5. Park DJ, Stoehlmacher J and Lenz HJ: Tailoring chemotherapy in advanced colorectal cancer. Curr Opin Pharmacol 3: 378-385, 2003.
6. Paradiso A, Simone G, Petroni S, Leone B, Vallejo C, Lacava J, Romero A, Machiavelli M, De Lena M, Allegra CJ and Johnston PG: Thymidilate synthase and p53 primary tumor expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82: 560-567, 2000.
7. Findlay MP, Cunningham D, Morgan G, Clinton S, Hardcastle A and Aherne GW: Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to chemotherapy. Br J Cancer 75: 903-909, 1997.
8. Aschele C, Debernardis D, Tunesi G, Maley F and Sobrero A: Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil. Clin Cancer Res 6: 4797-4802, 2000.
9. Johnston PG, Benson AB III, Catalano P, Rao MS, O'Dwyer PJ and Allegra CJ: Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. J Clin Oncol 21: 815-819, 2003.
10. Yamada H, Ichikawa W, Uetake H, Shirota Y, Nihei Z, Sugihara K and Hirayama R: Thymidylate synthase gene expression in primary colorectal cancer and metastatic sites. Clin Colorectal Cancer 1: 169-174, 2001.
11. Backus HH, van Groeningen CJ, Vos W, Dukers DF, Bloemena E, Wouters D, Pinedo HM and Peters GJ: Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours and liver metastases. J Clin Pathol 55: 206-211, 2002.
12. Inokuchi M, Uetake H, Shirota Y, Yamada H, Tajima M and Sugihara K: Gene expression of 5-fluorouracil metabolic enzymes in primary colorectal cancer and corresponding liver metastasis. Cancer Chemother Pharmacol 53: 391-396, 2004.
13. Shirota Y, Ichikawa W, Uetake H, Yamada H, Nihei Z and Sugihara K: Intratumoral dihydropyrimidine dehydrogenase messenger RNA level reflects tumor progression in human colorectal cancer. Ann Surg Oncol 9: 599-603, 2002.
14. Guimbaud R, Guichard S, Dusseau C, Bertrand V, Aparicio T, Lochon I, Chatelut E, Couturier D, Bugat R, Chaussade S and Canal P: Dihydropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humans. Cancer Chemother Pharmacol 45: 477-482, 2000.
15. Marsh S, McKay JA, Curran S, Murray GI, Cassidy J and McLeod HL: Primary colorectal tumour is not an accurate predictor of thymidylate synthase in lymph node metastasis. Oncol Rep 9: 231-234, 2002.
16. Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S and Liotta LA: Laser capture microdissection: molecular analysis of tissue. Science 278: 1481-1483, 1997.
17. Lord RV, Salonga D, Danenberg KD, Peters JH, De Meester TR, Park JM, Johansson J, Skinner KA, Chandrasoma P, De Meester SR, Bremner CG, Tsai PI and Danenberg PV: Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. J Gastrointest Surg 4: 135-142, 2000.
18. Heid CA, Stevens J, Livak KJ and Williams PM: Real-time quantitative PCR. Genome Res 6: 986-994, 1996.
19. Italian Network for Quality Assurance of Tumor Biomarkers (INQAT) Group: Interobserver reproducibility of immunohistochemical HER-2/neu evaluation in human breast cancer: the real-world experience. Int J Biol Markers 19: 147-154, 2004.
20. Kinzler K and Vogelstein B: Landscaping the cancer terrain. Science 279: 1036-1037, 1998.
21. Collie-Duguid ES, Johnston SJ, Boyce L, Smith N, Cowieson A, Cassidy J, Murray GI and McLeod HL: Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer. Int J Cancer 94: 297-301, 2001.
22. Miwa M, Ura M, Nishida M, Swada N, Ishikawa T, Mori K, Shimma N, Umeda I and Ishitsuka H: Design of a novel oral fluoropyrimidine carbamate, caecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concnetrted in human liver and cancer tissue. Eur J Biochem 34: 1274-1281, 1998.
23. Fujiwaki R, Hata K, Nakayama K, Fukumoto M and Miyazaki K: Gene expression for dihydropyrimidine dehydrogenase and thymidine phosphorylase influences outcome in epithelial ovarian cancer. J Clin Oncol 18: 3946-3951, 2000.
24. Hotta T, Taniguchi K, Kobayashi Y, Johata K, Sahara M, Naka T, Watanabe T, Ochiai M, Tanimura H and Tsubota YT: Comparative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in gastric and colorectal cancers. Oncol Rep 11: 1045-1051, 2004.
25. Tang W, Wang X, Utsunomiya H, Nakamuta Y, Yang Q, Zhang Q, Zhou G, Tsubota Y, Mabuchi Y, Li L and Kakudo K: Thymidine phosphorylase expression in tumor stroma of uterine cervical carcinomas: histological features and microvessel density. Cancer Lett 148: 153-159, 2000.
26. Saito S, Tsuno N, Nagawa H, Sunami E, Zhengxi J, Osada T, Kitayama J, Shibata Y, Tsuruo T and MutoT: Expression of platelet-derived endothelial cell growth factor correlates with good prognosis in patients with colorectal carcinoma. Cancer 88: 42-49, 2000.
27. Okada K, Yokoyama K, Okihara K, Ukimura O, Kojima M, Miki T and Takamatsu T: Immunohistochemical localization of platelet-derived endothelial cell growth factor expression and its relation to angiogenesis in prostate. Urology 57: 376-381, 2001.